ImmunityBio, Xencor Drugs Win E.U. Nods
ImmunityBio Wins U.K. Approval
Anktiva Approved For Additional Treatment
FDA Delivers Blow to ImmunityBio
ImmunityBio Seeks Drug Approvals
ImmunityBio Shares Plunge After Share Offering
ImmunityBio Drug Gets FDA Nod
ImmunityBio Gets $320M Investment
2025 CRE: LAND SALE OF THE YEAR
2025 CRE: MEDICAL LEASE OF THE YEAR
2025 CRE: BEST MULTIFAMILY SALE OF THE YEAR
LABJ Stock Index: January 12
LABJ Insider: Caltech Picks New President
